Jennison Associates’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,990,414
| Closed | -$16.3M | – | 618 |
|
|
2024
Q4 | $16.3M | Buy |
2,990,414
+9,769
| +0.3% | +$53.2K | 0.01% | 359 |
|
|
2024
Q3 | $24.8M | Sell |
2,980,645
-1,574,052
| -35% | -$13.1M | 0.02% | 322 |
|
|
2024
Q2 | $32.6M | Buy |
4,554,697
+4,160,803
| +1,056% | +$29.8M | 0.02% | 279 |
|
|
2024
Q1 | $3.42M | Buy |
+393,894
| New | +$3.42M | ﹤0.01% | 444 |
|
|
2023
Q4 | – | Sell |
-2,547,753
| Closed | -$25.5M | – | 608 |
|
|
2023
Q3 | $25.5M | Buy |
2,547,753
+769,362
| +43% | +$7.69M | 0.02% | 285 |
|
|
2023
Q2 | $22.1M | Hold |
1,778,391
| – | – | 0.02% | 305 |
|
|
2023
Q1 | $24.9M | Buy |
1,778,391
+343,464
| +24% | +$4.81M | 0.02% | 298 |
|
|
2022
Q4 | $20.5M | Buy |
+1,434,927
| New | +$20.5M | 0.02% | 320 |
|
|
2021
Q1 | – | Sell |
-265,386
| Closed | -$7.44M | – | 706 |
|
|
2020
Q4 | $7.44M | Buy |
+265,386
| New | +$7.44M | 0.01% | 430 |
|